Data as of Mar 07
| +0.07 / +1.99%|
The 2 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 3.00. The median estimate represents a +11.42% increase from the last price of 3.59.
The current consensus among 5 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.